A Selective TRPC3 Inhibitor Pyr3 Attenuates Myocardial Ischemia/Reperfusion Injury in Mice

Abstract

An emerging body of evidence indicates that transient receptor potential TRP channels act as important mediators for a wide variety of physiological functions and are potential targets for drug discovery. Our previous study has identified transient receptor potential channel 3 (TRPC3) and TRPC6 as cation channels through which most of the damaging calcium enters, aggravates pathological changes in vivo and increases ischemia/reperfusion (I/R) injury in mice. This study aimed to verify the effects of TRPC3 inhibitor Pyr3 on myocardial I/R injury in mice. C57BL/6J wild-type male mice (8 to 12 weeks old) were anesthetized with 3.3% chloral hydrate. A murine I (30 min)/R (24 h) injury model was established by temporary occlusion of the left anterior descending (LAD) coronary artery. Pyr3 was administered at concentrations of 0, 2.5, 5, or 10 mg/kg via the right jugular vein 5 min before reperfusion. We observed that the selective TRPC3 inhibitor, 10 mg/kg Pyr3, significantly decreased the infarct size of left ventricle, and reduced the myocardial cell apoptosis rate and inflammatory response in mice. In a conclusion, TRPC3 can function as a candidate target for I/R injury prevention, and Pyr3 may directly bind to TRPC3 channel protein, inhibit TRPC3 channel activity, and improve TRPC3-related myocardial I/R injury. Pyr3 may be used for clarification of TRPC3 functions and for treatments of TRPC3-mediated diseases.

Keywords

ischemia/reperfusion injury / TRPC3 / Pyr3 / apoptosis

References

[1] MurphyE, SteenbergenC. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev, 2008, 88(2): 581-609

[2] PaddisonPJ, ClearyM, SilvaJM, et al.. Cloning of short hairpin RNAs for gene knockdown in mammalian cells. Nat Methods, 2004, 1(2): 163-167

[3] KiyonakaS, KatoK, NishidaM, et al.. Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound. Proc Nat Acad Sci USA, 2009, 106(13): 5400-5405

[4] SeoK, RainerPP, Shalkey HahnV, et al.. Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy. Proc Nat Acad Sci USA, 2014, 111(4): 1551-1556

[5] KitajimaN, Numaga-TomitaT, WatanableM, et al.. TRPC3 positively regulates reactive oxygen species driving maladaptive cardiac remodeling. Sci Rep, 2016, 6: 37001

[6] HofmannT, ObukhovAG, SchaeferM, et al.. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature, 1999, 397(6716): 259-263

[7] KiselyovK, XuX, MozhayevaG, et al.. Functional interaction between InsP3 receptors and store-operated Htrp3 channels. Nature, 1998, 396(6710): 478-482

[8] TrebakM, BirdGS, McKayRR, et al.. Comparison of human TRPC3 channels in receptor-activated and store-operated modes. Differential sensitivity to channel blockers suggests fundamental differences in channel composition. J Biol Chem, 2002, 277(24): 21617-21623

[9] SmedlundK, VazquezG. Involvement of native TRPC3 proteins in ATP-dependent expression of VCAM-1 and monocyte adherence in coronary artery endothelial cells. Arterioscler Thromb Vasc Biol, 2008, 28(11): 2049-2055

[10] HaradaM, LuoX, QiXY, et al.. Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation, 2012, 126(17): 2051-2064

[11] DragoniS, LaforenzaU, BonettiE, et al.. Canonical transient receptor potential 3 channel triggers vascular endothelial growth factor-induced intracellular Ca²⁺ oscillations in endothelial progenitor cells isolated from umbilical cord blood. Stem Cells Dev, 2013, 22(19): 2561-2580

[12] KimDS, RyuHJ, KimJE, et al.. The reverse roles of transient receptor potential canonical channel-3 and −6 in neuronal death following pilocarpine-induced status epilepticus. Cell Mol Neurobiol, 2013, 33(1): 99-109

[13] KoenigS, SchernthanerM, MaechlerH, et al.. A TRPC3 blocker, ethyl-1-(4-(2,3,3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate (Pyr3), prevents stent-induced arterial remodeling. Pharmacol Exp Ther, 2013, 344(1): 33-40

[14] XijuH, ShoutianL, BenjuL, et al.. Major contribution of the 3/6/7 class of TRPC channels to myocardial ischemia/reperfusion and cellular hypoxia/reoxygenation injuries. Proc Nat Acad Sci USA, 2017, 114(23): E4582-E4591

[15] MunakataM, ShirakawaH, NagayasuK, et al.. Transient receptor potential canonical 3 inhibitor Pyr3 improves outcomes and attenuates astrogliosis after intracerebral hemorrhage in mice. Stroke, 2013, 44(7): 1981-1987

[16] BohlS, MedwayDJ, Schulz-MengerJ, et al.. Refined approach for quantification of in vivo ischemia-reperfusion injury in the mouse heart. Am J Physiol Heart Circ Physiol, 2009, 297(6): H2054-2058

[17] NishidaM, OnoharaN, SatoY, et al.. Galpha12/13-mediated up-regulation of TRPC6 negatively regulates endothelin-1-induced cardiac myofibroblast formation and collagen synthesis through nuclear factor of activated T cells activation. J Biol Chem, 2007, 282(32): 23117-23128

[18] BushEW, HoodDB, PapstPJ, et al.. Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling. J Biol Chem, 2006, 281(44): 33487-33496

[19] InoueR, JensenLJ, ShiJ, et al.. Transient receptor potential channels in cardiovascular function and disease. Circ Res, 2006, 99(2): 119-131

[20] ClaphamDE. TRP channels as cellular sensors. Nature, 2003, 426(6966): 517-524

[21] OhbaT, WatanableH, MurakamiM, et al.. Upregulation of TRPC1 in the development of cardiac hypertrophy. J Mol Cell Cardiol, 2007, 42(3): 498-507

[22] MakarewichCA, ZhangH, DavisJ, et al.. Transient receptor potential channels contribute to pathological structural and functional remodeling after myocardial infarction. Circ Res, 2014, 115(6): 567-580

[23] DietrichA, Mederos y SchnitzlerM, KalwaH, et al.. Functional characterization and physiological relevance of the TRPC3/6/7 subfamily of cation channels. Naunyn Schmiedebergs Arch Pharmacol, 2005, 371(4): 257-265

[24] KitajimaN, WatanableK, MorimotoS, et al.. TRPC3-mediated Ca²⁺ influx contributes to Rac1-mediated production of reactive oxygen species in MLP-deficient mouse hearts. Biochem Biophy Res Commun, 2011, 409(1): 108-113

[25] PanXC, LiZX, WuDZ, et al.. Mapping Changes of Whole Brain Blood Flow in Rats with Myocardial Ischemia/Reperfusion Injury Assessed by Positron Emission Tomography. Curr Med Sci, 2019, 39(4): 653-657

[26] SmedlundK, TanoJY, VazquezG. The constitutive function of native TRPC3 channels modulates vascular cell adhesion molecule-1 expression in coronary endothelial cells through nuclear factor κB signaling. Circ Res, 2010, 106: 1479-1488

[27] SermersheimM, KenneyAD, LinPH, et al.. MG53 suppresses interferon-β and inflammation via regulation of ryanodine receptor-mediated intracellular calcium signaling. Nat Commun, 2020, 11(1): 3624